Akoya (AKYA) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Akoya Biosciences Inc (AKYA) PT Lowered to $3.50 at Canaccord Genuity
November 15, 2024 6:22 AM ESTCanaccord Genuity analyst Kyle Mikson lowered the price target on Akoya Biosciences Inc (NASDAQ: AKYA) to $3.50 (from $6.00) while maintaining a Buy rating.
The analyst comments "We reiterate our BUY rating on Akoya Biosciences (AKYA) shares and decrease our price target to $3.50 from $6. Although... More
